Cited by 181Dementia and Cognitive Impairment ResearchIntensive Care Unit Cognitive DisordersAlzheimer's disease research and treatments

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder

Braak, Heiko, Braak, Eva·1994·Neurobiology of Aging

DOI 10.1016/0197-4580(94)90032-9

Open this paper in CoChat — free account

Integrity signals

Registry

Crossref · 10.1016/0197-4580(94)90032-9

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Neuropathological stageing of Alzheimer-related changes.
Braak, H., & Braak, E. (1991) · Acta Neuropathologica · doi:10.1007/bf00308809 · Cited by 16,123
Self-citation
The Consortium to Establish a Registry for Alzheimer's Disease (CERAD): Part II. Standardization of the neuropathologic assessment of Alzheimer's disease
Mirra, S. S., Heyman, A., McKeel, D., Sumi, S. M., Crain, B. J., Brownlee, L. M., Vogel, F. S., Hughes, J. P., Belle, G. V., Berg, L., et al. (1991) · Neurology · doi:10.1212/wnl.41.4.479 · Cited by 4,961
Diagnosis of Alzheimer's Disease
Khachaturian, Z. S. (1985) · Archives of Neurology · doi:10.1001/archneur.1985.04060100083029 · Cited by 2,499
The human nervous system
Paxinos, G., & Jürgen, K. (2004) · Cited by 1,478
The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease
Arnold, S. E., Hyman, B. T., Flory, J., Damasio, A. R., & Van Hoesen, G. W. (1991) · Cerebral Cortex · doi:10.1093/cercor/1.1.103 · Cited by 1,380
The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
Price, J. L., Davis, P. B., Morris, J. C., & White, D. L. (1991) · Neurobiology of Aging · doi:10.1016/0197-4580(91)90006-6 · Cited by 818
The NINCDS‐ADRDA Work Group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases
Tierney, M. C., Fisher, R. H., Lewis, A. J., Zorzitto, M. L., Snow, W. G., Reid, D. W., & Nieuwstraten, P. (1988) · Neurology · doi:10.1212/wnl.38.3.359 · Cited by 613
Architectonics of the Human Telencephalic Cortex
Braak, H. (1980) · Studies of brain function · doi:10.1007/978-3-642-81522-5 · Cited by 504
Self-citation
Entorhinal cortex pathology in Alzheimer's disease
van Hoesen, G. W., Hyman, B. T., & Damasio, A. R. (1991) · Hippocampus · doi:10.1002/hipo.450010102 · Cited by 475
The human entorhinal cortex: normal morphology and lamina-specific pathology in various diseases
Braak, H., & Braak, E. (1992) · Neuroscience Research · doi:10.1016/0168-0102(92)90014-4 · Cited by 334
Self-citation

Show all 14 references

Sorted by citations

Items 101–181 of 181

Targeting Cell Death in Dementia
Francis, P. T. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000213803.82058.46 · Cited by 22
Isoflurane anesthesia precipitates tauopathy and upper airways dysfunction in pre-symptomatic Tau.P301L mice: Possible implication for neurodegenerative diseases
Menuet, C., Borghgraef, P., Voituron, N., Gestreau, C., Gielis, L., Devijver, H., Dutschmann, M., LEUVEN, F. V., & Hilaire, G. (2012) · Neurobiology of Disease · doi:10.1016/j.nbd.2012.01.012 · Cited by 23
Low Serum Potassium in Mid Life Associated with Decreased Cerebrospinal Fluid Aβ42 in Late Life
Mielke, M. M., Zandi, P. P., Blennow, K., Gustafson, D., Sjögren, M. J. C., Rosengren, L., & Skoog, I. G. (2006) · Alzheimer Disease & Associated Disorders · doi:10.1097/01.wad.0000201848.67954.7d · Cited by 22
The Amyloid Hypothesis and the clearance and degradation of Alzheimer's β-peptide
LeVine, H. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6311 · Cited by 20
Modelling of amyloid β-peptide induced lesions using roller-drum incubation of hippocampal slice cultures from neonatal rats
Johansson, S. M., Radesäter, A., Cowburn, R. F., Thyberg, J., & Luthman, J. (2005) · Experimental Brain Research · doi:10.1007/s00221-005-0069-z · Cited by 19
Diffusion MR imaging in neuropsychiatry and aging
Adolf Pfefferbaum, A., & Sullivan, E. V. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9781139193481.041 · Cited by 19
Differential gene expression analysis of human entorhinal cortex support a possible role of some extracellular matrix proteins in the onset of Alzheimer disease
Santa‐María, I., Ávila, J., & Rábano, A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.11.002 · Cited by 18
Molecular Mechanisms of Neuronal Cell Death: Implications for Nuclear Factors Responding to cAMP and Phorbol Esters
Vyas, S., Biguet, N. F., Michel, P. P., Monaco, L., Foulkes, N. S., Evan, G. I., Sassone‐Corsi, P., & Agid, Y. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1170 · Cited by 18
Olfactory Dysfunction Is Associated with Cerebral Amyloid Deposition and Cognitive Function in the Trajectory of Alzheimer’s Disease
Wang, S., Kang, D. W., Um, Y. H., Kim, S., Lee, C. U., & Lim, H. K. (2023) · Biomolecules · doi:10.3390/biom13091336 · Cited by 17
Aging is associated with dimerization and inactivation of the brain-enriched tyrosine phosphatase STEP
Rajagopal, S., Deb, I., Poddar, R., & Paul, S. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.004 · Cited by 17
Genome instability biomarkers and blood micronutrient risk profiles associated with mild cognitive impairment and Alzheimer's disease
Lee, S. L., Thomas, P., & Fenech, M. F. (2015) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/j.mrfmmm.2014.12.012 · Cited by 18
Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain
Kubo, A., Ueda, S., Yamane, A., Wada‐Kakuda, S., Narita, M., Matsuyama, M., Nomori, A., Takashima, A., Kato, T., Onodera, O., et al. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.2845-18.2019 · Cited by 17
Caffeine as Treatment for Alzheimer's Disease: A Review
Mohan, A., Roberto, A. J., Mohan, A., Liogier-Weyback, L., Guha, R., Ravishankar, N., Rebello, C., Kumar, A., & Mohan, R. (2015) · Journal of Caffeine Research · doi:10.1089/jcr.2014.0027 · Cited by 15
SIRT1 Regulates Tau Expression and Tau Synaptic Pathology
Yin, X., Zhou, Z., Qiu, Y., Fan, X., Zhao, C., Bao, J., Liu, C., Liu, F., & Qian, W. (2021) · Journal of Alzheimer s Disease · doi:10.3233/jad-215118 · Cited by 15
Classification of Mild Cognitive Impairment and Alzheimer Disease Using Model-Based MR and Magnetization Transfer Imaging
Wiest, R., Burren, Y., Hauf, M., Schroth, G., Pruessner, J., Zbinden, M., Cattapan-Ludewig, K., & Kiefer, C. (2013) · American Journal of Neuroradiology · doi:10.3174/ajnr.a3307 · Cited by 13
The Role of Aβ-Peptide on Spatial Memory, EEG, Auditory Evoked Potentials And Nicotinic Cholinergic Receptors in A/P Transgenic Mice
Wang, J. (2003) · Cited by 14
Opportunities and Limitations of Modelling Alzheimer’s Disease with Induced Pluripotent Stem Cells
Ovchinnikov, D. A., & Wolvetang, E. J. (2014) · Journal of Clinical Medicine · doi:10.3390/jcm3041357 · Cited by 13
Effects of method and MRI slice thickness on entorhinal cortex volumetry
Bonilha, L., Kobayashi, E., Cendes, F., & Li, L. M. (2003) · Neuroreport · doi:10.1097/00001756-200307180-00001 · Cited by 12
Hippocampal glutamate-glutamine (Glx) in adults with Down syndrome: a preliminary study using in vivo proton magnetic resonance spectroscopy (1H MRS)
Tan, G. M., Beacher, F. D. C. C., Daly, E., Horder, J., Prasher, V., Hanney, M. L., Morris, R. G., Lovestone, S., Murphy, K. C., Simmons, A., et al. (2014) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-6-42 · Cited by 13
Protein Folding, Nucleation Phenomena and Delayed Neurodegeneration in Alzheimer's Disease
Fox, N. C., Harvey, R. J., & Rossor, M. N. (1996) · Reviews in the Neurosciences · doi:10.1515/revneuro.1996.7.1.21 · Cited by 11
Cell-death pathways and tau-associated neuronal vulnerability in Alzheimer’s disease
Lin, G., Chancellor, S. E., Kwon, T., Woodbury, M. E., Doering, A., Abdourahman, A., Bennett, R. E., Liao, F., Pastika, T., Tamm, J. A., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115758 · Cited by 15
First Clinical Evaluation of Ganstigmine in Patients With Probable Alzheimer's Disease
Jhee, S. S., Fabbri, L., Piccinno, A., Monici, P., Moran, S. E., Zarotsky, V., Tan, E. Y., Frackiewicz, E. J., & Shiovitz, T. M. (2003) · Clinical Neuropharmacology · doi:10.1097/00002826-200305000-00011 · Cited by 10
Assessing Competence of Broccoli Consumption on Inflammatory and Antioxidant Pathways in Restraint-Induced Models: Estimation in Rat Hippocampus and Prefrontal Cortex
Khalaj, L., Nejad, S. C., Mohammadi, M., Zadeh, S. S., Pour, M. H., Ashabi, G., Khodagholi, F., & Ahmadiani, A. (2013) · BioMed Research International · doi:10.1155/2013/590379 · Cited by 10
Influence of Nitric Oxide–Cyclic GMP and Oxidative STRESS on Amyloid-β Peptide Induced Decrease of Na,K-ATPase Activity in Rat Hippocampal Slices
Kawamoto, E. M., Cararo-Lopes, M. M., Kinoshita, P. F., Quintas, L. E. M., Lima, L. S., Andreotti, D. Z., & Scavone, C. (2021) · The Journal of Membrane Biology · doi:10.1007/s00232-021-00196-9 · Cited by 9
Brain amyloid and the transition to dementia in Down syndrome
Keator, D. B., Doran, E. W., Taylor, L., Phelan, M. J., Hom, C. L., Tseung, K., van Erp, T. G. M., Potkin, S. G., Brickman, A. M., Rosas, H. D., et al. (2020) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12126 · Cited by 9
Targeted downregulation of dMyc restricts neurofibrillary tangles mediated pathogenesis of human neuronal tauopathies in Drosophila
Chanu, S. I., & Sarkar, S. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.05.017 · Cited by 8
Neuroimaging in alzheimer’s disease: Relevance for treatment
van Dyck, C. H. (2001) · Current Psychiatry Reports · doi:10.1007/s11920-001-0066-2 · Cited by 8
Glutamate antibodies repress expression of Dffb gene in brain of rats in experimental Alzheimer’s disease
Викторович, К. В., Davydova, T. V., Ia, Z., Gorbatov, V. Y., & Fomina, V. G. (2012) · Molecular Biology · doi:10.1134/s0026893312040061 · Cited by 7
Molecular Design of Magnetic Resonance Imaging Agents Binding to Amyloid Deposits
Nikiforova, A. A., & Sedov, I. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241311152 · Cited by 7
Demise of the Flies
Bakhoum, M. F., & Jackson, G. R. (2011) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-384878-9.00011-x · Cited by 7
Common neurodegenerative disorders in the perioperative setting: Recommendations for screening from the Society for Perioperative Assessment and Quality Improvement (SPAQI)
Wiggins, M. E., Arias, F., Urman, R. D., Richman, D. C., Sweitzer, B. J., Edwards, A. F., Armstrong, M. J., Chopra, A., Libon, D. J., & Price, C. C. (2020) · Perioperative Care and Operating Room Management · doi:10.1016/j.pcorm.2020.100092 · Cited by 7
Olfaction and Alzheimer Disease
Lee, J. (2017) · Journal of rhinology · doi:10.18787/jr.2017.24.1.1 · Cited by 6
Preservation of hippocampal pyramidal cells in paraphrenia
Casanova, M. F. (2003) · Schizophrenia Research · doi:10.1016/s0920-9964(02)00409-7 · Cited by 6
Hippocampal magnetic resonance imaging morphometry and neuropsychological parameters in patients with Alzheimer's disease
Yakhno, N. N., Koberskaya, N. N., Андреевич, П. В., Smirnov, D. S., Игоревич, С. В., Труфанов, М. И., & Гридин, В. Н. (2019) · Neurology neuropsychiatry Psychosomatics · doi:10.14412/2074-2711-2019-4-28-32 · Cited by 5
Molecular changes of acetylcholinesterase and butyrylcholinesterase in Alzheimer patients during the natural couse of the disease and treatment with cholinesterase inhibitors : Insight into neurochemical mechanisms affecting the progression of the disease
Darreh‐Shori, T. (2006) · Figshare · Cited by 4
Brain activation in older adults during odor identification is related to ApoE, t-tau/Aβ1–42, and hippocampal volume
Albertazzi, A., & Murphy, C. (2025) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2025.02.001 · Cited by 3
alzheimer disease: New Concepts on Its Neurobiology and the Clinical
Jack, C. R., & Cme, O. (2012) · Cited by 3
Imaging biomarkers in Alzheimer's disease
Sudre, C. H., Cardoso, M. J., Marc Modat, A., & Sebastien Ourselin, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-816176-0.00020-x · Cited by 3
Neuroimaging in dementia syndromes
Rahmat, K., Phuah, A. H., Ramli, N. M., Gowdh, N. F. M., Chan, W. Y., & Tan, M. P. (2022) · Neurology Asia · doi:10.54029/2022aym · Cited by 3
Effects of Plasma from Patients Affected by Mild Cognitive Impairment and Alzheimer's Disease on Cultured Endothelial Cells
Salvolini, E., Vignini, A., Nanetti, L., Luzzi, S., Provinciali, L., Primio, R. D., & Mazzanti, L. (2013) · European Journal of Inflammation · doi:10.1177/1721727x1301100216 · Cited by 3
Search for reliable diagnostic markers for Alzheimer's disease
Andreasen, N. (2000) · Figshare · Cited by 3
Neuroprotective Role of Statins in Alzheimer's Disease: Anti-Apoptotic Signaling
Hunt, W. T., Salins, P. B., Anderson, C. M., & Amara, F. (2010) · The Open Neuroscience Journal · Cited by 2
Chapter 7 Neuronal Aging and Alzheimer's Disease
Bosman, G. J. C. G. M., & Grip, W. J. D. (1996) · Advances in cell aging and gerontology · doi:10.1016/s1566-3124(08)60042-5 · Cited by 2
[ 18 F]-Florbetapir PET: Towards Predicting Dementia in Adults with Down SyndromePreprint
Keator, D. B., Doran, E. W., van Erp, T. G. M., Phelan, M. J., Tseung, K., Yassa, M. A., Potkin, S. G., & Lott, I. T. (2018) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/235440 · Cited by 2
Clinical Trials to Prevent Alzheimer’s Disease in a Population At-Risk
Grundman, M., & Thai, L. J. (1997) · Birkhäuser Boston eBooks · doi:10.1007/978-1-4612-4116-4_56 · Cited by 2
Pathological Stages of Abnormally Processed Tau Protein During Its Aggregation into Fibrillary Structures in Alzheimer’s Disease
García‐Sierra, F., Basurto‐Islas, G., Jarero-Basulto, J., Hugo, C., Cruz, F. M. T., Cortés, H., Rojas, H., Krištofíková, Z., Řı́pová, D., Luna‐Muñoz, J., et al. (2011) · InTech eBooks · doi:10.5772/17077 · Cited by 2
Neuroprotective Role of Statins in Alzheimer`s Disease: Anti-Apoptotic Signaling~!2009-02-06~!2010-04-04~!2010-06-22~!
Hunt, W. T., Salins, P. B., Anderson, C. M., & Amara, F. (2010) · The Open Neuroscience Journal · doi:10.2174/1874082001004010013 · Cited by 1
In silico profiling of Cynodon dactylon L. Bioactives: Targeting Alzheimer’s pathways through network pharmacology, molecular docking and ADMET analysis
Pattanashetti, L. A., Patil, V. S., & Patil, B. M. (2024) · Indian Journal of Physiology and Pharmacology · doi:10.25259/ijpp_617_2023 · Cited by 1
Alzheimer’s Disease: A Clinical Perspective
Xu, W., Marseglia, A., Ferrari, C., & Wang, H. (2013) · InTech eBooks · doi:10.5772/54539 · Cited by 2
Smell and taste recognition in early stages of late-onset Alzheimer’s disease
Ilhamto, N., & Duizer, L. M. (2010) · SURG Journal · doi:10.21083/surg.v4i1.1189 · Cited by 1
Testing for Olfactory and Gustatory Disorders
Mun, S. J. (2020) · Journal of Clinical Otolaryngology Head and Neck Surgery · doi:10.35420/jcohns.2020.31.2.148 · Cited by 1
A Randomized, Placebo-Controlled Study of the Efficacy of Cognitive Intervention on Elderly People and on Patient’s with Alzheimer’s Disease
Yanguas, J. J., Buiza, C., Etxeberría, I., Galdona, N., González, M. F., & Urdaneta, E. (2006) · Lecture notes in computer science · doi:10.1007/11788713_111 · Cited by 1
Functional Brain Imaging of Cerebrovascular Disease
Cohen, R. A., Sweet, L. H., Tate, D. F., & Fisher, M. (2005) · Humana Press eBooks · doi:10.1385/1-59259-824-2:181 · Cited by 1
Modelling the Neuroanatomical Progression of Alzheimer's Disease and Posterior Cortical AtrophyPreprint
Marinescu, R. V. (2020) · arXiv (Cornell University) · doi:10.48550/arxiv.2003.04805 · Cited by 1
Lítio e expressão gênica: implicações para a doença de Alzheimer.
Mendes, C. T. (2008) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.87.2008.tde-10032009-113854
Obesity measure predict differences in Olfactory Event-Related Potential (OERP) latencies between Apolipoprotein E [lower case epislon]4 carriers and non-carriers
Cervantez, M. R. (2013) · CSUN ScholarWorks (California State University, Northridge)
Characterization of hippocampal slice cultures as model systems for neurodegenerative processes in Alzheimer´s disease
Johansson, S. M. (2005) · Figshare
In vitro modelling of tau phosphorylating kinases : emphasis of Cdk5
Jämsä, A. (2007) · Figshare
Implications of cholesterol and cholesterol-lowering therapy in Alzheimer s disease
Famer, D. (2007) · Figshare
Immune Responses in HIV Infection, Alcoholism, and Aging: A Neuroimaging Perspective
Zahr, N. M., Manning-Bog, A., Alt, C., Sullivan, E. V., & Adolf Pfefferbaum, A. (2012) · Springer eBooks · doi:10.1007/978-1-4614-4729-0_14
Imaging Approaches to Cerebral Cortex Pathology
Bartha, R., & Lee, T.-Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801942-9.00003-3
A Drosophila model of Alzheimer's disease
Crowther, D. C., Page, R., Chandraratna, D. S., & Lomas, D. A. (2006) · UCL Discovery (University College London)
The Role of PAK Signaling in Synaptic Transmission and Plasticity and Social Memory in Mice
Leung, C. (2019) · TSpace (University of Toronto)
HIPPOCAMPAL VOLUME BASED ON MRI-VOLUMETRIC ANALYSIS IN ALZHEIMER DISEASE PATIENTS
Yakhno, N. N., Гридин, В. Н., Андреевич, П. В., Sinitsyn, V. E., Koberskaya, N. N., Smirnov, D. S., Игоревич, С. В., & Труфанов, М. И. (2020) · Russian Electronic Journal of Radiology · doi:10.21569/2222-7415-2020-10-1-50-58
Role of Aβ Degrading Enzymes in Synaptic Plasticity and Neurogenesis in Alzheimer’s Disease
Crews, L. A., Spencer, B. J., & Masliah, E. (2009) · Springer eBooks · doi:10.1007/978-0-387-87995-6_1
Faculty Opinions recommendation of Atrophy of presubiculum and subiculum is the earliest hippocampal anatomical marker of Alzheimer's disease.
Lever, C., & Poulter, S. L. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.733246270.793571962
Systematic Review of glucose transporter alterations in human Alzheimer’s disease and rodent Alzheimer’s disease modelsPreprint
Hede, E., Burkhart, A., Aldana, B. I., Kohlmeier, K. A., Moos, T., & Thomsen, M. S. (2025) · Research Square · doi:10.21203/rs.3.rs-7374065/v1
Examining functional connectivity in metabolic syndrome and small vessel disease: A novel approach to understanding olfactory dysfunction and Alzheimer’s disease
Reyes, H. A., Mondragón, J. D., Frank, C., & Murphy, C. A. (2025) · Brain Research · doi:10.1016/j.brainres.2025.150084
Behavioral Aspects of Apolipoprotein E Knockout Mice
Litherland, M. T. (2003)
Olfactory Behavior in ApoE Knockout Mice
Yost, J. (2001) · Journal of Collective Bargaining in the Academy
Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer
Hamm, V. (2016) · theses.fr (ABES) · doi:10.70675/39443da7z44bfz4b29zbbbezb2b0dfba178a
Dérégulation de l’homéostasie calcique du réticulum endoplasmique dans la maladie d’Alzheimer : rôle du récepteur de la ryanodine et de l’isoforme SERCA1 tronquée
Bussiere, R. (2018) · theses.fr (ABES) · doi:10.70675/2334ca11z42bfz4e8bza53bz02e8bbacc38e
Second Section: A single domain antibody detects and neutralises toxic Aβ42 oligomers in the Alzheimer’s disease CSF
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.05
References
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.references
Discussion
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.07
Third Section: Design of a dimeric-nanobody specific for Aβ42 oligomers: the Dimeric-DesAb-O
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.06
A multidisciplinary approach for the early diagnosis of Alzheimer’s disease and potential therapeutic applications
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9
Material and Methods
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.03
First Section: Putative CSF biomarkers of Alzheimer’s disease based on the novel concept of generic protein misfolding and proteotoxicity: the PRAMA cohort
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.04
Introduction
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.02
Conclusion and Future Perspectives
Napolitano, L. (2026) · Firenze University Press eBooks · doi:10.36253/979-12-215-0993-9.08

Authors: Braak, H., & Braak, E.
Affiliations: Goethe University Frankfurt (DE)
ORCID: Braak, Heiko
Venue: Neurobiology of Aging
Publisher: Elsevier BV
Published: 1994-05
Volume: 15
Issue: 3
Pages: 355-356
ISSN: 0197-4580 (ISSN-L)
DOI: 10.1016/0197-4580(94)90032-9
OpenAlex: W1997018685
Cited by: 181
References: 14
Citations by year: 2026: 9 · 2025: 5 · 2024: 3 · 2023: 3 · 2022: 3 · 2021: 4 · 2020: 7 · 2019: 7 · 2018: 9 · 2017: 11 · 2016: 7 · 2015: 5 · 2014: 6 · 2013: 11 · 2012: 8
FWCI: 1.52
Type: journal article
Language: en
Open access: closed
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
Locations: Neurobiology of Aging (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Intensive Care Unit Cognitive Disorders
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
Keywords: Alzheimer's disease, neurodegenerative diseases, perioperative care, preoperative assessment, delirium, cognitive aging, behavioral characteristics, dementia screening, cortical changes, surgical patients
MeSH terms: Aged, Alzheimer Disease, Cerebral Cortex, Humans, Neurons, Pyramidal Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Morphological criteria for the recognition of Alzheimer's disease and the distribution pattern of cortical changes related to this disorder

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks